Multivalent group a streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments

Vaccine

Volumn 17, Issue 2, 1999, Pages 193-200

  Dale, James B ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Group A streptococci; Streptococcal vaccine; Tandem M protein fragments

Indexed keywords

ALUMINUM POTASSIUM SULFATE; BACTERIUM ANTIBODY; FREUND ADJUVANT; HYBRID PROTEIN; M PROTEIN; STREPTOCOCCUS VACCINE;

ANTIBODY TITER; ARTICLE; CROSS REACTION; DRUG DESIGN; HEART MUSCLE; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; RABBIT; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; SUBCUTANEOUS DRUG ADMINISTRATION;

ALUM COMPOUNDS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BACTERIAL VACCINES; CARRIER PROTEINS; CROSS REACTIONS; FREUND'S ADJUVANT; HUMANS; MYOCARDIUM; OPSONIN PROTEINS; PEPTIDE FRAGMENTS; RABBITS; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VACCINES, SYNTHETIC;

EID: 0032889976     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00150-9     Document Type: Article

References (17)

1. Davies H.D., McGeer A., Schwartz B.et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario group A Streptococcal study group. N. Engl. J. Med. 335:1996;547-554.
2. Veasey L.G., Wiedneier S.W., Osmond G.S.et al. Resurgence of acute rheumatic fever in the intermountain region of the United States. N. Engl. J. Med. 316:1987;421-427.
3. Lancefield R.C. Current knowledge of the type specific M antigens of group A streptococci. J. Immunol. 89:1962;307-313.
4. Lancefield R.C. Persistence of type-specific antibodies in man folowing infection with group A streptococci. J. Exp. Med. 110:1959;271-282.
5. Dale J.B., Beachey E.H. Multiple heart-cross-reactive epitopes of streptococcal M proteins. J. Exp. Med. 161:1985;113-122.
6. Baird R.W., Bronze M.S., Kraus W., Hill H.R., Veasey L.G., Dale J.B. Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium. J. Immunol. 146:1991;3132-3137.
7. Bronze M.S., Dale J.B. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J. Immunol. 151:1993;2820-2828.
8. Dale J.B., Chiang E.Y., Lederer J.W. Recombinant tetravalent group A streptococcal M protein vaccine. J. Immunol. 151:1993;2188-2194.
9. Dale J.B., Simmons M., Chiang E.C., Chiang E.Y. Recombinant, octavalent group A streptococcal M protein vaccine. Vaccine. 14:1996;944-948.
10. Dale J.B., Seyer J.M., Beachey E.H. Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein. J. Exp. Med. 158:1983;1727-1732.
11. Beachey E.H., Seyer J.M. Protective and nonprotective epitopes of chemically synthesized peptides of the NH2- terminal region of type 6 streptococcal M protein. J. Immunol. 136:1986;2287-2292.
12. Beachey E.H., Stollerman G.H., Johnson R.H., Ofek I., Bisno A.L. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein. J. Exp. Med. 150:1979;862-877.
13. Beachey E.H., Stollerman G.H., Chiang E.Y., Chiang T.M., Seyer J.M., Kang A.H. Purification and properties of M protein extracted from group A streptococci with pepsin: Covalent structure of the amino terminal region of the type 24 M antigen. J. Exp. Med. 145:1977;1469-1483.
14. Dale J.B., Ofek I., Beachey E.H. Heterogeneity of type-specific and cross-reactive antigenic determinants within a single M protein of group A streptococci. J. Exp. Med. 151:1980;1026-1038.
15. Dale J.B., Beachey E.H. Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J. Exp. Med. 156:1982;1165-1176.
16. Musser J.M., Kapur V., Szeto J., Pan X., Swanson D.S., Martin D.R. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect. Immun. 63:1995;994.
17. de Malmanche S.A., Martin D.R. Protective immunity to the group A streptococcus may be only strain specific. Med. Microbiol. Immunol. 183:1994;299-306.